NCT02251171View on ClinicalTrials.gov

Effects of Steady-state TPV/RTV on the Single-dose Pharmacokinetics of Rifabutin and the Effects of Single-dose Rifabutin on the Steady-state Pharmacokinetics of TPV in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

October 31, 2003

Conditions
Healthy
Interventions
DRUG

Tipranavir

DRUG

Ritonavir

DRUG

Rifabutin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY